Publications 2022

Cocchetti C, Romani A, Collet S, Greenman Y, Schreiner T, Wiepjes C, den Heijer M, T'Sjoen G, Fisher AD (2022)
The ENIGI (European Network for the Investigation of Gender Incongruence) Study: Overview of Acquired Endocrine Knowledge and Future Perspectives
J Clin Med, 11 (7)
DOI 10.3390/jcm11071784, PubMed 35407392

Klaver M, van Velzen D, de Blok C, Nota N, Wiepjes C, Defreyne J, Schreiner T, Fisher A, Twisk J, Seidell J, T'Sjoen G, den Heijer M, de Mutsert R (2022)
Change in Visceral Fat and Total Body Fat and the Effect on Cardiometabolic Risk Factors During Transgender Hormone Therapy
J Clin Endocrinol Metab, 107 (1), e153-e164
DOI 10.1210/clinem/dgab616, PubMed 34415999

Publications 2021

Cocchetti C, Castellini G, Iacuaniello D, Romani A, Maggi M, Vignozzi L, Schreiner T, den Heijer M, T'Sjoen G, Fisher AD (2021)
Does Gender-Affirming Hormonal Treatment Affect 30-Year Cardiovascular Risk in Transgender Persons? A Two-Year Prospective European Study (ENIGI)
J Sex Med, 18 (4), 821-829
DOI 10.1016/j.jsxm.2021.01.185, PubMed 33745831

Stangl TA, Wiepjes CM, Defreyne J, Conemans E, D Fisher A, Schreiner T, T'Sjoen G, den Heijer M (2021)
Is there a need for liver enzyme monitoring in people using gender-affirming hormone therapy?
Eur J Endocrinol, 184 (4), 513-520
DOI 10.1530/EJE-20-1064, PubMed 33524005

Publications 2020

Defreyne J, Aers XP, Collet SM, Wiepjes CM, Fisher AD, Schreiner T, Den Heijer M, Kaufman JM, T'Sjoen GGR (2020)
Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence
LGBT Health, 7 (2), 71-81
DOI 10.1089/lgbt.2019.0260, PubMed 32049583

Defreyne J, Vanwonterghem Y, Collet S, Iwamoto SJ, Wiepjes CM, Fisher AD, Schreiner T, Heijer MD, T'Sjoen G (2020)
Vaginal bleeding and spotting in transgender men after initiation of testosterone therapy: A prospective cohort study (ENIGI)
Int J Transgend Health, 21 (2), 163-175
DOI 10.1080/26895269.2020.1719951, PubMed 32935087

Publications 2019

Scharff M, Wiepjes CM, Klaver M, Schreiner T, T'Sjoen G, den Heijer M (2019)
Change in grip strength in trans people and its association with lean body mass and bone density
Endocr Connect, 8 (7), 1020-1028
DOI 10.1530/EC-19-0196, PubMed 31247588

Publications 2018

de Blok CJM, Klaver M, Wiepjes CM, Nota NM, Heijboer AC, Fisher AD, Schreiner T, T'Sjoen G, den Heijer M (2018)
Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study
J Clin Endocrinol Metab, 103 (2), 532-538
DOI 10.1210/jc.2017-01927, PubMed 29165635

Publications 2017

Defreyne J, Nota N, Pereira C, Schreiner T, Fisher AD, den Heijer M, T'Sjoen G (2017)
Transient Elevated Serum Prolactin in Trans Women Is Caused by Cyproterone Acetate Treatment
LGBT Health, 4 (5), 328-336
DOI 10.1089/lgbt.2016.0190, PubMed 28880825

Wiepjes CM, Vlot MC, Klaver M, Nota NM, de Blok CJ, de Jongh RT, Lips P, Heijboer AC, Fisher AD, Schreiner T, T'Sjoen G, den Heijer M (2017)
Bone Mineral Density Increases in Trans Persons After 1 Year of Hormonal Treatment: A Multicenter Prospective Observational Study
J Bone Miner Res, 32 (6), 1252-1260
DOI 10.1002/jbmr.3102, PubMed 28370342

Publications 2015

Seland M, Bjøro T, Furre T, Schreiner T, Bollerslev J, Fosså SD, Loge JH, Holte H, Kiserud CE (2015)
Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region
J Cancer Surviv, 9 (4), 630-40
DOI 10.1007/s11764-015-0439-x, PubMed 25750158

Seland M, Holte H, Bjøro T, Schreiner T, Bollerslev J, Loge JH, Fosså SD, Kiserud CE (2015)
Chronic fatigue is prevalent and associated with hormonal dysfunction in long-term non-Hodgkin lymphoma survivors treated with radiotherapy to the head and neck region
Leuk Lymphoma, 56 (12), 3306-14
DOI 10.3109/10428194.2015.1036258, PubMed 25827172

Publications 2014

Wierckx K, Van Caenegem E, Schreiner T, Haraldsen I, Fisher AD, Toye K, Kaufman JM, T'Sjoen G (2014)
Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence
J Sex Med, 11 (8), 1999-2011
DOI 10.1111/jsm.12571, PubMed 24828032

Publications 2013

Jørgensen AP, Ueland T, Sode-Carlsen R, Schreiner T, Rabben KF, Farholt S, Høybye C, Christiansen JS, Bollerslev J (2013)
Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study
Growth Horm IGF Res, 24 (1), 16-21
DOI 10.1016/j.ghir.2013.11.002, PubMed 24360789

Papathomas TG, Gaal J, Corssmit EP, Oudijk L, Korpershoek E, Heimdal K, Bayley JP, Morreau H, van Dooren M, Papaspyrou K, Schreiner T, Hansen T, Andresen PA, Restuccia DF, van Kessel I, van Leenders GJ, Kros JM, Looijenga LH, Hofland LJ, Mann W, van Nederveen FH, Mete O, Asa SL, de Krijger RR, Dinjens WN (2013)
Non-pheochromocytoma (PCC)/paraganglioma (PGL) tumors in patients with succinate dehydrogenase-related PCC-PGL syndromes: a clinicopathological and molecular analysis
Eur J Endocrinol, 170 (1), 1-12
DOI 10.1530/EJE-13-0623, PubMed 24096523

Publications 2011

Carlsen SM, Svartberg J, Schreiner T, Aanderud S, Johannesen O, Skeie S, Lund-Johansen M, Fougner SL, Bollerslev J, POTA study group (2011)
Six-month preoperative octreotide treatment in unselected, de novo patients with acromegaly: effect on biochemistry, tumour volume, and postoperative cure
Clin Endocrinol (Oxf), 74 (6), 736-43
DOI 10.1111/j.1365-2265.2011.03982.x, PubMed 21521254

Ramm-Pettersen J, Berg-Johnsen J, Hol PK, Roy S, Bollerslev J, Schreiner T, Helseth E (2011)
Intra-operative MRI facilitates tumour resection during trans-sphenoidal surgery for pituitary adenomas
Acta Neurochir (Wien), 153 (7), 1367-73
DOI 10.1007/s00701-011-1004-7, PubMed 21523361

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C (2011)
Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study
Endocrine, 41 (2), 191-9
DOI 10.1007/s12020-011-9560-4, PubMed 22081257

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Frystyk J, Christiansen JS, Höybye C (2011)
Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome
Growth Horm IGF Res, 21 (4), 185-90
DOI 10.1016/j.ghir.2011.05.002, PubMed 21664161

Publications 2010

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C (2010)
Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome
Growth Horm IGF Res, 20 (3), 179-84
DOI 10.1016/j.ghir.2009.12.004, PubMed 20199883

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C (2010)
One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study
J Clin Endocrinol Metab, 95 (11), 4943-50
DOI 10.1210/jc.2010-0907, PubMed 20702523

Publications 2009

Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust P, Bollerslev J (2009)
Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly
J Clin Endocrinol Metab, 95 (1), 361-8
DOI 10.1210/jc.2009-0422, PubMed 19880791

Publications 2008

Carlsen SM, Lund-Johansen M, Schreiner T, Aanderud S, Johannesen O, Svartberg J, Cooper JG, Hald JK, Fougner SL, Bollerslev J, Preoperative Octreotide Treatment of Acromegaly study group (2008)
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial
J Clin Endocrinol Metab, 93 (8), 2984-90
DOI 10.1210/jc.2008-0315, PubMed 18492760

Vik-Mo EO, Øksnes M, Pedersen PH, Wentzel-Larsen T, Rødahl E, Thorsen F, Schreiner T, Aanderud S, Lund-Johansen M (2008)
Gamma knife stereotactic radiosurgery of Nelson syndrome
Eur J Endocrinol, 160 (2), 143-8
DOI 10.1530/EJE-08-0687, PubMed 18996962